Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Portugal Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20141
20151
20161
20181
20192
20201
20214
20222
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6
Completed5
Recruiting4
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Theravance Biopharma3
Centro Hospitalar Tondela-Viseu2
Eli Lilly and Company2
University of Coimbra2
AbbVie1
Bristol-Myers Squibb1
GlaxoSmithKline1
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa1
InDex Pharmaceuticals1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases19
Colitis, Ulcerative9
Crohn Disease8
Gastrointestinal Diseases2
Dysbiosis1
Hemostatic Disorders1
Thromboembolism1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.